High-sensitivity C-reactive protein in the low- and intermediate-Framingham risk score groups: Analysis with 18F-fluorodeoxyglucose positron emission tomography

International Journal of Cardiology

Volumn 163, Issue 3, 2013, Pages 277-281

  Yang, Sae Jeong ^a   Kim, Sungeun ^b   Choi, Hae Yoon ^a   Kim, Tae Nyun ^c   Yoo, Hye Jin ^a   Seo, Ji A ^a   Kim, Sin Gon ^a   Kim, Nan Hee ^a   Baik, Sei Hyun ^a   Choi, Dong Seop ^a   Choi, Kyung Mook ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

Author keywords

Atherosclerosis; Framingham risk score; High sensitivity C reactive protein; Inflammation; Positron emission tomography

Indexed keywords

C REACTIVE PROTEIN; FLUORODEOXYGLUCOSE F 18; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; INSULIN RESISTANCE; MALE; MOLECULAR IMAGING; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PULSE WAVE; RISK ASSESSMENT; VASCULITIS; ARTERIAL STIFFNESS; BRACHIAL ANKLE PULSE WAVE VELOCITY; PHYSICAL PARAMETERS; POSITRON EMISSION TOMOGRAPHY; TARGET TO BACKGROUND RATIO; WAIST CIRCUMFERENCE;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RISK FACTORS;

EID: 84874531706     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.054     Document Type: Article

References (32)

1. S. Mora, K. Musunuru, and R.S. Blumenthal The clinical utility of high-sensitivity C-reactive protein in cardiovascular disease and the potential implication of JUPITER on current practice guidelines Clin Chem 55 2009 219 228
2. A.P. Burke, R.P. Tracy, and F. Kolodgie Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies Circulation 105 2002 2019 2023
3. P.M. Ridker, J.E. Buring, N. Rifai, and N.R. Cook Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score JAMA 297 2007 611 619
4. S. Ben-Haim, and O. Israel PET/CT for atherosclerotic plaque imaging Q J Nucl Med Mol Imaging 50 2006 53 60
5. W. Chen, G.G. Bural, D.A. Torigian, D.J. Rader, and A. Alavi Emerging role of FDG-PET/CT in assessing atherosclerosis in large arteries Eur J Nucl Med Mol Imaging 36 2009 144 151
6. 18F- fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 2006 1818 1824
7. 18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2002 2708 2711
8. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 2007 1533 1539
9. E.E. van der Wall, J.D. Schuijf, J.W. Jukema, J.J. Bax, and A. van der Laarse Atherosclerotic plaque imaging by PET/CT; can inactive, active and mixed plaques be discerned? Int J Cardiovasc Imaging 25 2009 141 144
10. W.T. Friedewald, R.I. Levy, and D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
11. S.M. Kim, J. Lee, and O.H. Ryu Serum osteoprotegerin levels are associated with inflammation and pulse wave velocity Clin Endocrinol (Oxf) 63 2005 594 598
12. G.K. Hansson Inflammation, atherosclerosis, and coronary artery disease N Engl J Med 352 2005 1685 1695
13. J. Danesh, J.G. Wheeler, and G.M. Hirschfield C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
14. C.J. Lavie, R.V. Milani, A. Verma, and J.H. O'Keefe C-reactive protein and cardiovascular diseases - is it ready for primetime? Am J Med Sci 338 2009 486 492
15. M. Cushman, A.M. Arnold, and B.M. Psaty C-reactive protein and the 10-year incidence of coronary heart disease in older men and women: the cardiovascular health study Circulation 112 2005 25 31
16. S.M. Boekholdt, C.E. Hack, and M.S. Sandhu C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003 Atherosclerosis 187 2006 415 422
17. P.M. Ridker, N.P. Paynter, N. Rifai, J.M. Gaziano, and N.R. Cook C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men Circulation 118 2008 2243 2251 4p following 51
18. T. Inoue, T. Kato, and T. Uchida Local release of C-reactive protein from vulnerable plaque or coronary arterial wall injured by stenting J Am Coll Cardiol 46 2005 239 245
19. F. Montecucco, and F. Mach New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor Clin Interv Aging 3 2008 341 349
20. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
21. A. Tawakol, R.Q. Migrino, and U. Hoffmann Noninvasive in vivo measurement of vascular inflammation with F-18 fluorodeoxyglucose positron emission tomography J Nucl Cardiol 12 2005 294 301
22. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831
23. 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations J Nucl Med 49 2008 871 878
24. 18F-Fluorodeoxyglucose positron emission tomography 2010 Circ Cardiovasc Imaging
25. 18F-Fluorodeoxyglucose positron emission tomography Arterioscler Thromb Vasc Biol 31 2011 944 949
26. H.J. Yoo, S. Kim, and M.S. Park Serum adipocyte fatty acid-binding protein is associated independently with vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography J Clin Endocrinol Metab 96 2011 15
27. H.T. Nguyen-Thanh, and B.S. Benzaquen Screening for subclinical coronary artery disease measuring carotid intima media thickness Am J Cardiol 104 2009 1383 1388
28. K. Hirata, M. Kawakami, and M.F. O'Rourke Pulse wave analysis and pulse wave velocity: a review of blood pressure interpretation 100 years after Korotkov Circ J 70 2006 1231 1239
29. H. Tomiyama, Y. Koji, and M. Yambe Brachial-ankle pulse wave velocity is a simple and independent predictor of prognosis in patients with acute coronary syndrome Circ J 69 2005 815 822
30. T. Shokawa, M. Imazu, and H. Yamamoto Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study Circ J 69 2005 259 264
31. K. Cruickshank, L. Riste, S.G. Anderson, J.S. Wright, G. Dunn, and R.G. Gosling Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation 106 2002 2085 2090
32. K. Sharma, M.J. Blaha, R.S. Blumenthal, and K. Musunuru Clinical and research applications of carotid intima-media thickness Am J Cardiol 103 2009 1316 1320